Merck & Co. · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← MRK

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-30	16.61	+5.1%	73.5%	—	-1.34	-8.0%	4.48	-0.54	0.76	2.14
FY2026 Q1	2026-03-31	16.29	+4.9%	74.2%	—	-4.24	-26.0%	2.93	-1.72	0.87	2.11
FY2025 Q4	2025-12-31	16.40	+5.0%	66.2%	—	2.96	18.1%	1.82	1.19	1.25	2.02
FY2025 Q3	2025-09-30	17.28	+3.7%	77.7%	—	5.79	33.5%	6.84	2.32	1.32	2.03
FY2025 Q2	2025-06-30	15.81	−1.9%	77.5%	—	4.43	28.0%	2.53	1.76	1.35	2.08
FY2025 Q1	2025-03-31	15.53	−1.6%	78.0%	—	5.08	32.7%	1.17	2.01	1.16	2.05
FY2024 Q4	2024-12-31	15.62	+6.8%	75.5%	—	3.74	24.0%	2.51	1.49	0.49	1.95
FY2024 Q3	2024-09-30	16.66	+4.4%	75.5%	—	3.16	19.0%	8.51	1.24	0.44	1.95
FY2024 Q2	2024-06-30	16.11	+7.2%	76.8%	—	5.46	33.9%	4.85	2.14	0.25	1.99
FY2024 Q1	2024-03-31	15.78	+8.9%	77.6%	—	4.76	30.2%	2.23	1.87	0.12	1.95
FY2023 Q4	2023-12-31	14.63	+5.8%	73.3%	—	-1.23	-8.4%	-0.74	-0.48	0.39	1.85
FY2023 Q3	2023-09-30	15.96	+6.7%	73.3%	—	4.75	29.7%	6.82	1.86	0.47	1.86
FY2023 Q2	2023-06-30	15.04	—	73.2%	—	-5.98	-39.7%	2.74	-2.35	0.34	1.89
FY2023 Q1	2023-03-31	14.49	—	72.9%	—	2.82	19.5%	0.33	1.11	0.15	1.85
FY2022 Q4	2022-12-31	13.83	—	71.9%	—	3.02	21.8%	3.28	1.18	0.00	1.75
FY2022 Q3	2022-09-30	14.96	—	73.7%	—	3.25	21.7%	5.60	1.28	0.00	1.75

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.